Lygos
YC W16 ↗San Francisco, US · Delaware corporation · 55 employees · 8 known investors
Lygos uses genetically engineered microorganisms to produce industrial chemicals from sugar feedstocks, focusing on compounds where fermentation offers cost advantages compared to fossil fuel-based manufacturing.
Founders & leadership· Y Combinator alumni (W16)
ES
Eric SteeninFounder/CSO
JD
Jay D. KeaslingDirector
JA
Jeffrey A. DietrichExecutive Officer, Director
LK
Leonard KatzDirector
Investors · 8
Fifty YearsSan Francisco · $250K – $2M
FundersClubSan Francisco · $250K – $5M
LG Technology VenturesSanta Clara
Y CombinatorSan Francisco · $500K
10x FoundersreportedMünchen · $270K – $2.7M
First Round CapitalreportedSan Francisco · $2M
IA VenturesreportedNew York · $100K – $5M
OS FundreportedPark Ridge · $1M – $2M
Reported raises · per SEC filings
Form D private placements▶$10.9MraisedApr 2019 · 8 investors · Other TechnologyRule 506(b)
▶$10.9MraisedApr 2019 · 8 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Eric SteenExecutive Officer, Director
- Jay KeaslingDirector
- Brad GillespieDirector
- Jeffrey DietrichExecutive Officer
- Offering amount
- $15M
- Amount sold
- $10.9M
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15.5MraisedApr 2019 · 31 investors · Other TechnologyRule 506(b)
▶$15.5MraisedApr 2019 · 31 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Eric SteenExecutive Officer, Director
- Jay KeaslingDirector
- Jeffrey DietrichExecutive Officer
- Brad GillespieDirector
- Offering amount
- $20M
- Amount sold
- $15.5M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$14.1MraisedJul 2017 · 35 investors · Other TechnologyRule 506(b)
▶$14.1MraisedJul 2017 · 35 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Eric SteenExecutive Officer, Director
- Jeffrey DietrichExecutive Officer
- Brad GillespieDirector
- Jay KeaslingDirector
- Offering amount
- $14.1M
- Amount sold
- $14.1M
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.2MraisedFeb 2016 · 13 investors · OtherRule 506(b)
▶$1.2MraisedFeb 2016 · 13 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Eric SteenExecutive Officer, Director
- Jay D. KeaslingDirector
- Jeffrey A. DietrichExecutive Officer, Director
- Leonard KatzDirector
- Offering amount
- $2.9M
- Amount sold
- $1.2M
- First sale
- Jan 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Lygos and Ginkgo Bioworks Announce Partnership to Optimize Production of Biobased Specialty Chemicals - Lygoslygos.com · 2022
- Cannabis Researchers Seek to Unlock the Healing Power of Pot - WSJwsj.com · 2021
- Lygos takes in $15.5 mln Series Bventurecapitaljournal.com · 2018